What's breaking now, across thousands of outlets.
The milestone marks a significant expansion of digital healthcare delivery in the country, with eSanjeevani enabling patients to access medical consultations remotely and helping bridge geographical barriers to healthcare
We haven't written up this one. ETHealthworld has the full story — the link below goes straight to it.
For the first time in a human trial, a class of drugs known as sodium-glucose cotransporter-2 (SGLT2) inhibitors, already known for their weight-loss and glucose-lowering benefits, has also been shown to reduce inflammatory cells in the blood known to cause cardiovascular disease. The findings were published in Circulation.
As these honorees show, the future of medicine is looking more and more . . . futuristic. They include AI that diagnoses more than a dozen serious conditions from a single abdominal scan, a sci-fi-worthy clinic that reimagines the preventive care model, and a psychedelic that tackles treatment-resistant depression with a synthetic version…
Some innovations have potential beyond the bounds of a single industry. These honorees include a company that is combining AI and advanced genetic life science to better track disease pathology, and another developing models that could help avoid animal testing by simulating human organ functions.
As many as 21 dengue cases have been reported in the federal capital so far this year, according to the … Read More The post Islamabad Reports 21 Dengue Cases appeared first on ProPakistani .
AbbVie and Genmab said their T-cell engager Epkinly passed a late-stage trial in first-line diffuse large B-cell lymphoma, clearing the way for a potential market showdown with Roche’s antibody-drug conjugate Polivy. The companies tested Epkinly ...
Sensible Biotechnologies raised $47 million to scale VECTOR, its integrated platform pairing AI-enabled mRNA design with manufacturing of naturally modified mRNA in living cells, aiming to develop novel therapeutics beyond vaccines.
